기사

[The Economist Korea, Reporter Kim Jung-min] Regenerative medicine company PRODIZEN announced on the 28th that it has signed a strategic Memorandum of Understanding (MOU) with The Day Labs to collaborate on the clinical application of PRP-related products and technologies and the development of clinical protocols.

Under the agreement, the two companies will work together to apply PRODIZEN’s PRP technology in real-world clinical settings and establish and refine application protocols based on feedback and clinical experience from healthcare professionals.

Ceramique Clinic’s Gangnam and Myeongdong branches have been designated as “PRODIZEN Clinical Partner Clinics.” The two companies plan to incorporate clinical experience and feedback from healthcare professionals at these clinics into the development and refinement of PRP application protocols.

PRODIZEN will provide the partner clinics with PRP-related products and technical materials, as well as training and technical support to help healthcare professionals effectively use and apply the products in clinical practice.

The Day Labs will facilitate communication with participating medical institutions and healthcare professionals and share insights and on-site feedback gathered throughout the clinical application process.

Going forward, the two companies plan to expand PRP-related educational and academic activities by leveraging the experience and data accumulated through the clinical partner clinics. They also intend to continuously broaden their collaborative network to support the wider clinical application of PRP.

A PRODIZEN representative said, “This agreement goes beyond product supply. It is significant because it establishes a clinical collaboration framework that connects real-world medical experience with PRODIZEN’s PRP technology. Through our collaboration with Ceramique Clinic, we will continue to incorporate feedback from clinical practice and work toward establishing a more systematic environment for PRP application.”

The representative added, “We will continue to expand our collaborative network with medical institutions and healthcare professionals to enhance the clinical utilization of PRP technology and strengthen our competitiveness in the field.”

PRODIZEN CEO Sim Soo-ja (left) and The Day Labs CEO Lee Jong-jin (right). (Photo courtesy of PRODIZEN)